Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Total Current Liabilities (2023 - 2025)

Historic Total Current Liabilities for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $11.9 million.

  • Upstream Bio's Total Current Liabilities rose 950.89% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year increase of 950.89%. This contributed to the annual value of $10.7 million for FY2024, which is 6480.43% up from last year.
  • As of Q3 2025, Upstream Bio's Total Current Liabilities stood at $11.9 million, which was up 950.89% from $10.9 million recorded in Q2 2025.
  • Upstream Bio's 5-year Total Current Liabilities high stood at $11.9 million for Q3 2025, and its period low was $6.5 million during Q4 2023.
  • For the 3-year period, Upstream Bio's Total Current Liabilities averaged around $10.1 million, with its median value being $10.8 million (2024).
  • Its Total Current Liabilities has fluctuated over the past 5 years, first soared by 6480.43% in 2024, then surged by 950.89% in 2025.
  • Quarter analysis of 3 years shows Upstream Bio's Total Current Liabilities stood at $6.5 million in 2023, then surged by 64.8% to $10.7 million in 2024, then increased by 10.91% to $11.9 million in 2025.
  • Its Total Current Liabilities was $11.9 million in Q3 2025, compared to $10.9 million in Q2 2025 and $9.6 million in Q1 2025.